JP2017524344A - バイオフィルムの阻害及び分散における可溶性細菌及び真菌タンパク質並びに方法並びにそれらの使用 - Google Patents

バイオフィルムの阻害及び分散における可溶性細菌及び真菌タンパク質並びに方法並びにそれらの使用 Download PDF

Info

Publication number
JP2017524344A
JP2017524344A JP2016571249A JP2016571249A JP2017524344A JP 2017524344 A JP2017524344 A JP 2017524344A JP 2016571249 A JP2016571249 A JP 2016571249A JP 2016571249 A JP2016571249 A JP 2016571249A JP 2017524344 A JP2017524344 A JP 2017524344A
Authority
JP
Japan
Prior art keywords
domain
soluble protein
amino acids
genbank
accession number
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2016571249A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017524344A5 (enExample
Inventor
ハウエル，リン
ベイカー，ペリン
アルナベルセヤ，ヌール
バンフォード，ナタリー
リトル，ダスティン
シェパード，ドナルド
スナー，ブレンダン
ジョー リー，マーク
ジョー リー，マーク
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
Original Assignee
Hospital for Sick Children HSC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC filed Critical Hospital for Sick Children HSC
Publication of JP2017524344A publication Critical patent/JP2017524344A/ja
Publication of JP2017524344A5 publication Critical patent/JP2017524344A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/10—Animals; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/30—Microbial fungi; Substances produced thereby or obtained therefrom
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
    • A01N63/50—Isolated enzymes; Isolated proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2420/00—Materials or methods for coatings medical devices
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2430/00—Materials or treatment for tissue regeneration
    • A61L2430/24—Materials or treatment for tissue regeneration for joint reconstruction
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Dermatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
JP2016571249A 2014-06-06 2015-06-05 バイオフィルムの阻害及び分散における可溶性細菌及び真菌タンパク質並びに方法並びにそれらの使用 Pending JP2017524344A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462008836P 2014-06-06 2014-06-06
US62/008,836 2014-06-06
PCT/CA2015/000361 WO2015184526A1 (en) 2014-06-06 2015-06-05 Soluble bacterial and fungal proteins and methods and uses thereof in inhibiting and dispersing biofilm

Publications (2)

Publication Number Publication Date
JP2017524344A true JP2017524344A (ja) 2017-08-31
JP2017524344A5 JP2017524344A5 (enExample) 2018-07-12

Family

ID=54765890

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016571249A Pending JP2017524344A (ja) 2014-06-06 2015-06-05 バイオフィルムの阻害及び分散における可溶性細菌及び真菌タンパク質並びに方法並びにそれらの使用

Country Status (6)

Country Link
US (2) US10905749B2 (enExample)
EP (1) EP3152303B1 (enExample)
JP (1) JP2017524344A (enExample)
AU (1) AU2015271666B2 (enExample)
CA (1) CA2951152A1 (enExample)
WO (1) WO2015184526A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE112008001301T5 (de) 2007-05-14 2010-04-29 Reserach Foundation Of State University Of New York Induktion einer physiologischen Dispersions-Antwort in Bakterien-Zellen in einem Biofilm
CN105963680B (zh) 2015-03-13 2020-04-17 中国科学院微生物研究所 用于抑制/瓦解生物被膜的抑制剂及其应用
DK3330349T3 (da) * 2016-12-02 2024-07-15 Procter & Gamble Rengøringssammensætninger, der indbefatter enzymer
US10550443B2 (en) * 2016-12-02 2020-02-04 The Procter & Gamble Company Cleaning compositions including enzymes
MX2019006421A (es) * 2016-12-02 2019-08-01 Procter & Gamble Composiciones de limpieza que incluyen enzimas.
WO2018185152A1 (en) * 2017-04-04 2018-10-11 Novozymes A/S Polypeptide compositions and uses thereof
US20200109354A1 (en) * 2017-04-04 2020-04-09 Novozymes A/S Polypeptides
CN110651029B (zh) * 2017-04-04 2022-02-15 诺维信公司 糖基水解酶
WO2018185269A1 (en) * 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
WO2018185280A1 (en) * 2017-04-06 2018-10-11 Novozymes A/S Cleaning compositions and uses thereof
US11407964B2 (en) 2017-04-06 2022-08-09 Novozymes A/S Cleaning compositions and uses thereof
JP6647653B2 (ja) * 2017-05-02 2020-02-14 国立大学法人東北大学 変異型糸状菌及び当該変異型糸状菌を用いた物質生産方法
EP3728569A4 (en) 2017-12-21 2021-12-01 The New Zealand Institute For Plant And Food Research Limited BIOLOGICAL CONTROL BY VIRAL MEDIATION AGAINST PATHOGENIC MICRO-ORGANISMS OF PLANTS
US11541105B2 (en) 2018-06-01 2023-01-03 The Research Foundation For The State University Of New York Compositions and methods for disrupting biofilm formation and maintenance
US11878050B2 (en) * 2018-07-16 2024-01-23 Texas Tech University System Glycoside hydrolases to treat biofilm-associated infections
KR102225240B1 (ko) * 2019-07-03 2021-03-10 경북대학교 산학협력단 다제내성 병원성 세균을 효과적으로 사멸시키는 재조합 항균 단백질 Ablysin의 용도
CN111019876B (zh) * 2019-12-30 2023-04-28 延安大学 一种铜绿假单胞菌工程菌的构建方法及应用
CN111172134B (zh) * 2020-02-10 2022-05-17 山东大学 一种抗胰蛋白酶的胞外水解酶及其应用
WO2021168572A1 (en) * 2020-02-25 2021-09-02 Kane Biotech Inc. Stable liquid dispersinb compositions
CN116348580B (zh) * 2020-10-29 2025-10-24 宝洁公司 含有藻酸酶的清洁组合物
CN113584010A (zh) * 2021-08-30 2021-11-02 上海海洋大学 细菌生物被膜核心胞外多糖裂解酶PelAN及其制备方法和应用
CN117050208B (zh) * 2023-09-14 2024-03-22 成都大学 一种猕猴桃幼果多糖提取物及其制备方法和用途
WO2025106896A1 (en) * 2023-11-17 2025-05-22 Rush University Medical Center Coating of medical and implant biomaterials with an anti-biofilm agent to prevent and treat infection
CN118127051B (zh) * 2024-02-06 2024-10-29 河北农业大学 一种StGh93p1基因及其编码蛋白在防治玉米大斑病中的应用

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006511226A (ja) * 2002-12-20 2006-04-06 ユニバーシティー オブ メディシン アンド デンティストリー オブ ニュージャージー 細菌性および真菌性生物膜の酵素による剥離のための組成物および方法
WO2008157350A2 (en) * 2007-06-14 2008-12-24 Mayo Foundation For Medical Education And Research Methods and materials for reducing biofilms

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5264558A (en) 1987-06-19 1993-11-23 The Regents Of The University Of California Single-chain monellin analog as a low calorie protein sweetner
US6830745B1 (en) 1997-10-16 2004-12-14 Pharmacal Biotechnologies, Llc Compositions for treating biofilm
US6551795B1 (en) * 1998-02-18 2003-04-22 Genome Therapeutics Corporation Nucleic acid and amino acid sequences relating to pseudomonas aeruginosa for diagnostics and therapeutics
RU2165995C1 (ru) 1999-10-05 2001-04-27 Государственное предприятие "Всероссийский научно-исследовательский институт авиационных материалов" Высокопрочный сплав на основе алюминия и изделие, выполненное из этого сплава
GB0300597D0 (en) 2003-01-10 2003-02-12 Microbiological Res Authority Phage biofilms
JP5087741B2 (ja) 2003-11-19 2012-12-05 フェネックス インコーポレイテッド 改良タンパク質発現系

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006511226A (ja) * 2002-12-20 2006-04-06 ユニバーシティー オブ メディシン アンド デンティストリー オブ ニュージャージー 細菌性および真菌性生物膜の酵素による剥離のための組成物および方法
WO2008157350A2 (en) * 2007-06-14 2008-12-24 Mayo Foundation For Medical Education And Research Methods and materials for reducing biofilms

Non-Patent Citations (36)

* Cited by examiner, † Cited by third party
Title
BALES, P.M. ET AL., PLOS ONE, vol. 8, no. 6, JPN6021020799, 2013, pages 67950 - 1, ISSN: 0004518829 *
BAMFORD, N.C. ET AL., J. BIOL. CHEM., vol. 290, no. 46, JPN6019018646, 13 November 2015 (2015-11-13), pages 27438 - 27450, ISSN: 0004039997 *
BARDALAYE, P.C. AND NORDIN, J.H., J. BACTERIOL., vol. 125, no. 2, JPN6021020811, 1976, pages 655 - 669, ISSN: 0004518835 *
BOK, J.-D. ET AL., APPL. ENVIRON. MICROBIOL., vol. 64, no. 12, JPN6021020803, 1998, pages 4774 - 4781, ISSN: 0004518831 *
BOYD, A. AND CHAKRABARTY, A.M., APPL. ENVIRON. MICROBIOL., vol. 60, no. 7, JPN6020016818, 1994, pages 2355 - 2359, ISSN: 0004270078 *
BUGLI, F. ET AL., ANTIMICROB. AGENTS CHEMOTHER., vol. 57, no. 3, JPN6019018669, 2013, pages 1275 - 1282, ISSN: 0004040000 *
DAROUICHE, R.O. ET AL., J. ANTIMICROB. CHEMOTHER., vol. 64, JPN7019001637, 2009, pages 88 - 93, ISSN: 0004040006 *
DESAI, J.V. ET AL., COLD SPRING HARB. PERSPECT. MED., vol. 4, JPN6019018670, October 2014 (2014-10-01), pages 019729 - 1, ISSN: 0004040001 *
FONTAINE, T. ET AL., PLOS PATHOG., vol. 7, no. 11, JPN6021020793, 2011, pages 1002372 - 1, ISSN: 0004518828 *
GOMEZ-MIRANDA, B. AND LEAL, J.A., TRANS. BR. MYCOL. SOC., vol. 76, no. 2, JPN6021020812, 1981, pages 249 - 253, ISSN: 0004518836 *
HARRY, S., TRENDS GLYCOSCI. GLYCOTECHNOL., vol. 21, no. 119, JPN6020016830, 2009, pages 131 - 148, ISSN: 0004270091 *
HENRISSAT, B., BIOCHEM. J., vol. 280, JPN6020016825, 1991, pages 309 - 316, ISSN: 0004270089 *
ICHINOSE, Y., ET AL., JPN. J. PHYTOPATHOL, vol. 80, JPN6020016822, November 2014 (2014-11-01), pages 97 - 103, ISSN: 0004270081 *
INTRA, J. ET AL., BMC EVOLUTIONARY BIOLOGY, vol. 8, JPN6020016820, 2008, pages 214 - 1, ISSN: 0004270080 *
J. BIOL. CHEM., vol. 290, no. 46, JPN6019018648, 13 November 2015 (2015-11-13), pages 27451, ISSN: 0004040004 *
KAPLAN, J.B. ET AL., J. DENT. RES., vol. 89, no. 3, JPN6020016817, 2010, pages 205 - 218, ISSN: 0004270077 *
KAPLAN, J.B., INT. J. ARTIF. ORGANS, vol. 32, no. 9, JPN6019018665, 2009, pages 545 - 554, ISSN: 0004039991 *
KRIVENTSEVA, E.V. ET AL., NUCL. ACIDS RES., vol. 47, JPN6020016834, 2018, pages 807 - 811, ISSN: 0004270093 *
LE MAUFF, F. ET AL., J. BIOL. CHEM., vol. 294, no. 28, JPN6021020805, 2019, pages 10760 - 10772, ISSN: 0004518832 *
LEE, M.J. ET AL., MBIO, vol. 7, no. 2, JPN6021020818, 2016, pages 00252 - 16, ISSN: 0004518837 *
LEE, M.J., A THESIS SUBMITTED TO MCGILL UNIVERSITY IN PARTIAL FULFILLMENT OF THE REQUIREMENTS OF THE DEGREE OF, vol. pp.1-238, JPN6019018664, August 2014 (2014-08-01), ISSN: 0004040002 *
MIYAZAWA, K. ET AL., FUNGAL BIOL. BIOTECHNOL., vol. 7, JPN6021020807, 2020, pages 10 - 1, ISSN: 0004518833 *
MUSZKIETA, L. ET AL., FRONT. MICROBIOL., vol. 4, JPN6019018643, 2013, pages 13 - 1, ISSN: 0004039999 *
RAMASUBBU, N. ET AL., J. MOL. BIOL., vol. 349, JPN6019018661, 2005, pages 475 - 486, ISSN: 0004039994 *
RUPEREZ, P. AND LEAL, J.A., TRANS. BR. MYCOL. SOC., vol. 77, JPN6019018666, 1981, pages 621 - 625, ISSN: 0004039995 *
SHEPPARD, D. ET AL., MYCOSES, vol. Vol.58, Suppl.4, JPN6019018651, October 2015 (2015-10-01), pages 212, ISSN: 0004040005 *
SNARR, B.D. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 114, no. 27, JPN6019018667, 2017, pages 7124 - 7129, ISSN: 0004039996 *
TAKADA, H. ET AL., J. BIOCHEM., vol. 89, JPN6021020809, 1981, pages 1265 - 1274, ISSN: 0004518834 *
THORN, C.R. ET AL., ACS APPL. BIO. MATER., vol. 1, no. 2, JPN6020016832, 2018, pages 281 - 288, ISSN: 0004270092 *
TURK, R. ET AL., VET. MICROBIOL., vol. 166, JPN6019018671, 2013, pages 576 - 579, ISSN: 0004040003 *
WATERHOUSE, R.M. ET AL., NUCL. ACIDS RES., vol. 41, JPN6019018654, 2012, pages 358 - 365, ISSN: 0004039992 *
WOZNIAK, D.J. ET AL., PROC. NATL. ACAD. SCI. USA, vol. 100, no. 13, JPN6021020801, 2003, pages 7907 - 7912, ISSN: 0004518830 *
YAMAGISHI, A., J. GEOG., vol. 112, no. 2, JPN6020016828, 2003, pages 197 - 207, ISSN: 0004270090 *
YOSHIDA, K. ET AL., PLANT CELL PHYSIOL., vol. 47, no. 11, JPN6020016824, 2006, pages 1555 - 1571, ISSN: 0004270088 *
分子細胞生物学辞典, vol. 第1版, 第5刷, JPN6019018656, 2002, pages 153, ISSN: 0004039993 *
水之江義充, 耳展, vol. 56, no. 4, JPN6019018668, 2013, pages 199 - 203, ISSN: 0004039998 *

Also Published As

Publication number Publication date
WO2015184526A1 (en) 2015-12-10
US20170216410A1 (en) 2017-08-03
EP3152303A4 (en) 2018-03-21
US20210138044A1 (en) 2021-05-13
EP3152303B1 (en) 2021-11-24
US11672846B2 (en) 2023-06-13
AU2015271666A1 (en) 2017-01-19
EP3152303A1 (en) 2017-04-12
US10905749B2 (en) 2021-02-02
CA2951152A1 (en) 2015-12-10
AU2015271666B2 (en) 2021-07-08

Similar Documents

Publication Publication Date Title
US11672846B2 (en) Soluble bacterial and fungal proteins and methods and uses thereof in inhibiting and dispersing biofilm
Ma et al. Regulation of biofilm exopolysaccharide biosynthesis and degradation in Pseudomonas aeruginosa
Kapil et al. d-Amino acids in antimicrobial peptides: A potential approach to treat and combat antimicrobial resistance
Qin et al. Formation and properties of in vitro biofilms of ica-negative Staphylococcus epidermidis clinical isolates
De La Fuente-Núñez et al. Inhibition of bacterial biofilm formation and swarming motility by a small synthetic cationic peptide
Guan et al. Extra sugar on vancomycin: new analogues for combating multidrug-resistant Staphylococcus aureus and vancomycin-resistant Enterococci
Yadav et al. Deciphering streptococcal biofilms
Grishin et al. Resistance to peptidoglycan-degrading enzymes
Okano et al. Total Syntheses and Initial Evaluation of [Ψ [C ( S) NH] Tpg4] vancomycin,[Ψ [C ( NH) NH] Tpg4] vancomycin,[Ψ [CH2NH] Tpg4] vancomycin, and Their (4-Chlorobiphenyl) methyl Derivatives: Synergistic Binding Pocket and Peripheral Modifications for the Glycopeptide Antibiotics
Pokrovskaya et al. Functional characterization of Staphylococcus epidermidis IcaB, a de-N-acetylase important for biofilm formation
AU2018384790C1 (en) Identification of lysins and derivatives thereof with bacterial activity against pseudomonas aeruginosa
Eitzen et al. A fungal member of the Arabidopsis thaliana phyllosphere antagonizes Albugo laibachii via a GH25 lysozyme
Zheng et al. Diclazuril inhibits biofilm formation and hemolysis of Staphylococcus aureus
US20130156737A1 (en) Secretion System and Methods for its Use
Bowden et al. Beyond the double helix: the multifaceted landscape of extracellular DNA in Staphylococcus aureus biofilms
Li et al. Development of antibacterial peptides with membrane disruption and Folate Pathway Inhibitory activities against Methicillin-Resistant Staphylococcus aureus
Ovchinnikova et al. Surface thermodynamic and adhesion force evaluation of the role of chitin-binding protein in the physical interaction between Pseudomonas aeruginosa and Candida albicans
Luo et al. Studies on the antibacterial activity and mechanism of antimicrobial peptides against drug-resistant bacteria
Zha et al. Lysostaphin: engineering and potentiation toward better applications
Wang et al. Streptothricin-F inhibition of FtsZ function: a promising approach for controlling pseudomonas syringae pv. Actinidiae
Saini et al. Targeting Vancomycin-Resistant Enterococci (VRE) Infections and Van Operon-Mediated Drug Resistance Using Dimeric Cholic Acid–Peptide Conjugates
Zhang et al. Cationic glycosylated block Co-β-peptide acts on the cell wall of gram-positive bacteria as anti-biofilm agents
Balomenou et al. Polysaccharide deacetylases: New antibacterial drug targets
Shen et al. Triintsin, a human pathogenic fungus-derived defensin with broad-spectrum antimicrobial activity
Cools et al. In vitro and in vivo evaluation of in silico predicted pneumococcal UDPG: PP inhibitors

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180604

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180604

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190528

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20190822

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20191127

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20191128

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200602

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201201

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210602